• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, February 7, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Raging Bull: First study to find link between testosterone and stock market instability

Bioengineer by Bioengineer
October 10, 2017
in Biology
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Key Takeaway: Increasing testosterone levels in men, who make up the majority of professional stock market traders, causes them to bid up prices, which create price bubbles and crashes.

CATONSVILLE, MD, Oct. 10, 2017 – In the U.S. today, the majority of professional stock market traders are young males and new evidence suggests biology strongly influences their trading behavior. According to a new study in the INFORMS journal Management Science, this could be a significant contributor to fluctuations in the market, as high testosterone levels can cause these traders to overestimate future stock values and change their trading behavior, leading to dangerous prices bubbles and subsequent crashes.

The study, "The Bull of Wall Street: Experimental Analysis of Testosterone and Asset Trading," was conducted by Amos Nadler of the Ivey Business School at Western University, Peiran Jiao of the University of Oxford, Paul Zak and Veronika Alexander of the Center for Neuroeconomics Studies at Claremont Graduate University, and Cameron Johnson at the Behavioral Health Institute at Loma Linda.

The double blind study involved 140 young males, each of whom received a topical gel containing either testosterone or a placebo, prior to participating in an experimental asset market in which they were able to post bid and ask prices, as well as buy and sell financial assets to earn real money.

The authors found that among groups that received testosterone relative to those who received a placebo, larger price bubbles formed, mispricing lasted longer, market dynamics changed to reflect increasing bidding and selling volume, and their perception of a stock's value changed despite its being displayed throughout the study. While the traders who received the placebo displayed "buy low to sell high" behavior, those who had received testosterone adhered to "buy high to sell higher."

"This research suggests the need to consider hormonal influences on decision-making in professional settings, because biological factors can exacerbate capital risk," said Nadler. "Perhaps the simplest recommendation is to implement 'cool down' periods to interrupt exceptionally positive feedback cycles and return the focus to assets' fundamental valuations to reduce the possibility of biased decision-making."

"Based on our findings, professional traders, investment advisories, and hedge funds should limit the risk taken by young male traders," continued Nadler. "This is the first study to have shown that testosterone changes the way the brain calculates value and returns in the stock market and therefore – testosterone's neurologic influence will cause traders to make suboptimal decisions unless systems prevent them from occurring."

###

The full study is available here http://pubsonline.informs.org/stoken/default+domain/MNSC-PR-10-2017/full/10.1287/mnsc.2017.2836.

About INFORMS and Management Science

INFORMS is the leading international association for operations research and analytics professionals. Management Science, one of 14 journals published by INFORMS, is a premier academic journal that covers groundbreaking research on all aspects of the practice of management. More information is available at http://www.informs.org or @informs.

Media Contact

Ashley Kilgore
[email protected]
443-757-3560
@INFORMS

http://www.informs.org

http://ow.ly/sFOM30fMnNE

Share12Tweet7Share2ShareShareShare1

Related Posts

New Study Uncovers Mechanism Behind Burn Pit Particulate Matter–Induced Lung Inflammation

New Study Uncovers Mechanism Behind Burn Pit Particulate Matter–Induced Lung Inflammation

February 6, 2026

DeepBlastoid: Advancing Automated and Efficient Evaluation of Human Blastoids with Deep Learning

February 6, 2026

Navigating the Gut: The Role of Formic Acid in the Microbiome

February 6, 2026

AI-Enhanced Optical Coherence Photoacoustic Microscopy Revolutionizes 3D Cancer Model Imaging

February 6, 2026
Please login to join discussion

POPULAR NEWS

  • Robotic Ureteral Reconstruction: A Novel Approach

    Robotic Ureteral Reconstruction: A Novel Approach

    82 shares
    Share 33 Tweet 21
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    57 shares
    Share 23 Tweet 14
  • Breakthrough in RNA Research Accelerates Medical Innovations Timeline

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Succinate Receptor 1 Limits Blood Cell Formation, Leukemia

Palmitoylation of Tfr1 Drives Platelet Ferroptosis and Exacerbates Liver Damage in Heat Stroke

Oxygen-Enhanced Dual-Section Microneedle Patch Improves Drug Delivery and Boosts Photodynamic and Anti-Inflammatory Treatment for Psoriasis

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 73 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.